WEBCLIP: Mini-lab - 01. Fighting antibiotic resistance (ENG)

An easily transportable laboratory to enable analysis in the field and thus help fight against antibiotic resistance.

MSF220156

If you think this image is in any way inappropriate, please report it, by including its URN/identifying code and a brief description of your concern in sending an email to [email protected]

Linked assets

WEBCLIP: Mini-lab - 01. Lutter contre l'antibiorésistance (FR)

Subt. French

VIDEOS: Innovation. Mini-lab

Add to lightbox

Add to cart

Unique Identifier Code / URN MSF220156

Date taken / Date Recorded 02/11/2017 12:00 AM

Country France

Commissioning section MSF-FRANCE

Photographer / videographer / producer Benoit Finck

Usage Rights (MSF) External Media, MSF Fundraising, MSF Publications, Social Media

Formal Consent Copy available no

Editor's rating ★★★★★ (C)

Video format h264 (Constrained Baseline) (avc1 / 0x31637661)

Duration 4m50s

Maximum Size 1920px × 1080px 497.63 MB

Additional Information / Shotlist CARTON
// Projet
Transportable laboratory
SYNTHE
Dr Thierry Naas
Director of the National Reference Center of Antibiotic Resistance
Antibiotic resistance is a major public health issue affecting the whole world. We’re seeing more and more bacteria becoming resistant to antibiotics, and sometimes to all antibiotics.

SYNTHE
Dr Tamman Aloudat
Deputy Medical Director, MSF Suisse (IN ENGLISH)
Years ago, we were able to treat most infections with simple antibiotics. This is not the case anymore.

Dr Thierry Naas
Overuse of antibiotics and misuse of antibiotics particularly for viral illnesses contribute to the occurrence and the spread of these resistances.

Dr Tamman Aloudat (IN ENGLISH)
DIAGNOSIS
As a physician, my primary concern is always the patient that I am treating. And if I have the ability to diagnose them accurately I’ll use the right antibiotic, for example, for an infection. But if I don’t, my inclination would be to use the strongest, most complicated antibiotic to guarantee that my patient survives. And what we need to provide our physicians and nurses and medical staff in the field is with the precise tools that allow them to achieve both: a diagnostic capacity that allows them to treat the patient as efficiently as possible while using the least broad-spectrum, the least sporadic way of prescribing antibiotics.
En tant que médecin, ma priorité sera toujours le patient que je soigne. Et si j’ai ce qu’il y a de mieux, si je peux faire un diagnostic précis, j’utilisera par exemple l’antibiotique le mieux adapté à son infection. Mais si je ne peux pas, je préfère utiliser l’antibiotique le plus fort, le plus perfectionné, qui garantira la survie de mon patient. Ce qu’il faut, c’est fournir à nos médecins, nos infirmiers, tout notre personnel médical sur le terrain un outil précis pour, d’une part, faire un diagnostic qui leur permet de traiter leurs patients le plus efficacement possible, et d’autre part d’utiliser les antibiotiques de manière moins large, plus raisonnée.

IN THE LABORATORY
In bacteriological laboratories, blood culture vials are placed in a machine that monitors the potential growth of bacteria in the vials. The microbiologists use the positive vials to grow a bacterial culture and then test the bacteria causing the infection for its sensitivity to antibiotics. The results are recorded on an antibiogram to be sent to the clinician who uses it to provide treatment appropriate to their patients’ infections.

IN THE FIELD
Jean-Baptiste Ronat
MSF has decided to develop a transportable bacteriological laboratory adapted to conditions in the field.

Dr Tamman Aloudat (IN ENGLISH)
In a traditional MSF context you might be faced with anything, from being deployed very rapidly in an acute emergency to being in a very remote area.
Dans un contexte MSF classique, tout peut arriver : être envoyé très rapidement sur une urgence grave ou bien travailler dans un endroit très isolé .

SYNTHE
Jan Jacobs (IN ENGLISH)
Head the Unit of Tropical Laboratory Medicine at the Institute of Tropical Medicine (ITM) in Antwerp, Belgium.
WARNING
Clinical microbiology – TRAINING A, B, C, D, E
A relative humidity can affect electronics, high temperature can affect stability of consumables. Dust can block several equipments. Short shelf-life is difficult for procurement, cold chain is difficult for transport and for storage. Most clinicians have never used clinical microbiology in their practice so they do not know about indications sampling and they cannot make a good interpretation of a microbiological result. Next, there’s also a problem of affordable, available and adapted training materials.
L’humidité interfère avec l’électronique, la chaleur joue sur la stabilité des consommables. Trop de poussière peut mettre en panne certains équipements. La courte durée de vie complique l’approvisionnement. La chaine de froid complique le transport et le stockage. La plupart des médecins n’ont jamais eu à utiliser la microbiologie clinique. Ils ne savent donc pas quels prélèvements faire, ni interpréter correctement un résultat microbiologique. Un autre problème, c’est le manque de matériel de formation abordable, disponible et adapté … .

Jean-Baptiste Ronat
So we’re going to modify existing technologies to make them more user-friendly and robust at a reasonable price.

WHERE ARE WE AT WITH THE PROJECT?

SYNTHE
Jean-Baptiste Ronat
M.Sc., MPH, Microbiologist
Project manager, MSF France
Concretely, the aim now is to be able to adapt the equipment so that it works in settings with temperatures of 45°C but also with low temperatures, that it uses as little electricity as possible, or even with no electricity for a certain amount of time. For diagnosis tests, we’re trying to ensure that these tools have a service life of more than 18 months to have an easier to manage logistics supply chain.
The first stage in developing a product is drafting the specifications so that it’s adapted to conditions in the field, working with international experts but also specialists at MSF who have knowledge of the field. Then we look at what’s available on the market and find manufacturers able to adapt their solutions to our specifications. We’re going to integrate them into transportable, modular solutions that will be then tested in the field. We hope to have the first prototypes by the end of 2018 so as to be able to test them in various places where MSF works during 2019.

MANUFACTURERS
DRAFTING SPECIFICATIONS – ADAPTING INDUSTRIAL SOLUTIONS – TRANSPORTABLE SOLUTIONS – PROTOTYPES – 1st PROTYPE END 2018 – TESTING
2019